Edition:
United States

PAREXEL International Corp (PRXL.OQ)

PRXL.OQ on NASDAQ Stock Exchange Global Select Market

65.88USD
23 Feb 2017
Change (% chg)

-- (--)
Prev Close
$65.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
324,321
52-wk High
$72.22
52-wk Low
$51.18

PRXL.OQ

Chart for PRXL.OQ

About

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $3,356.89
Shares Outstanding(Mil.): 50.95
Dividend: --
Yield (%): --

Financials

  PRXL.OQ Industry Sector
P/E (TTM): 23.43 44.59 29.71
EPS (TTM): 2.81 -- --
ROI: 11.73 -3.18 12.94
ROE: 28.49 5.86 14.09

BRIEF-Parexel International enters into a supplier receivables purchase agreement with BofA

* On February 22, 2017, Parexel International entered into a supplier receivables purchase agreement with Bank of America

Feb 23 2017

BRIEF-Parexel International launches ClinPhone RTSM mobile app

* Launched a mobile app for ClinPhone RTSM service Source text for Eikon: Further company coverage:

Feb 13 2017

BRIEF-Parexel International reports Q2 GAAP earnings $0.41/shr

* Parexel international reports second quarter fiscal year 2017 results

Feb 01 2017

BRIEF-Parexel International agrees to acquire Medical Affairs Company

* Parexel announces definitive agreement to acquire the Medical Affairs Company

Feb 01 2017

BRIEF-Parexel International approved plan to restructure its operations on Jan. 6, 2017,

* Parexel international corp - on January 6, 2017, approved plan to restructure its operations - sec filing

Jan 09 2017

BRIEF-Parexel International to buy shares of its stock for $200 mln - SEC filing

* On Nov 21, Co entered agreement to buy shares of its stock from HSBC Bank USA, National Association for $200 million-SEC filing Source text: (http://bit.ly/2fOzbhU) Further company coverage:

Nov 22 2016

BRIEF-Parexel International Corp files for non-timely 10-Q

* Parexel International Corp files for non-timely 10-Q - sec filing

Nov 10 2016

BRIEF-Parexel International Q1 adjusted earnings per share $0.76

* Q1 earnings per share view $0.85 -- Thomson Reuters I/B/E/S

Oct 26 2016

BRIEF-PAREXEL announces execution of agreement to acquire ExecuPharm

* PAREXEL announces execution of definitive agreement to acquire ExecuPharm

Sep 26 2016

More From Around the Web

Earnings vs. Estimates